TFOS DEWS II management and therapy report

L Jones, LE Downie, D Korb, JM Benitez-del-Castillo… - The ocular …, 2017 - Elsevier
The members of the Management and Therapy Subcommittee undertook an evidence-
based review of current dry eye therapies and management options. Management options …

Dry eye syndrome preferred practice pattern®

EK Akpek, G Amescua, M Farid, FJ Garcia-Ferrer… - …, 2019 - aaojournal.org
Dry Eye Syndrome Preferred Practice Pattern® - Ophthalmology Skip to Main Content
Advertisement Ophthalmology Home Page AAO Submit Log in Register Log in Submit Log …

Autologous serum eye drops for dry eye

Q Pan, A Angelina, M Marrone… - Cochrane Database …, 2017 - cochranelibrary.com
Background Theoretically, autologous serum eye drops (AS) offer a potential advantage
over traditional therapies on the assumption that AS not only serve as a lacrimal substitute to …

Blood derived eye drops for the treatment of cornea and ocular surface diseases

G Giannaccare, P Versura, M Buzzi, L Primavera… - … and Apheresis Science, 2017 - Elsevier
The use of blood derived eye drops for the treatment of ocular surface disorders has become
increasingly popular in recent years. The mechanism of action is the stimulation of cellular …

Treatment of non-infectious corneal injury: review of diagnostic agents, therapeutic medications, and future targets

DH Dang, KM Riaz, D Karamichos - Drugs, 2022 - Springer
Corneal injuries can occur secondary to traumatic, chemical, inflammatory, metabolic,
autoimmune, and iatrogenic causes. Ocular infection may frequently occur concurrent to …

Autologous serum 50% eyedrops in the treatment of persistent corneal epithelial defects

BH Jeng, WJ Dupps Jr - Cornea, 2009 - journals.lww.com
Purpose: To evaluate the success rate of treating persistent corneal epithelial defects using
50% autologous serum eyedrops. Methods: We reviewed the medical records of all patients …

Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German–Austrian–Swiss Consensus Conference on Clinical Practice in Chronic …

T Dietrich-Ntoukas, C Cursiefen, H Westekemper… - Cornea, 2012 - journals.lww.com
Purpose: Ocular chronic graft-versus-host disease (cGVHD) is one of the most frequent long-
term complications after hematopoietic stem cell transplantation and is often associated with …

A review of ocular graft-versus-host disease

SZ Munir, J Aylward - Optometry and Vision Science, 2017 - journals.lww.com
Graft-versus-host disease (GVHD) is a major complication that occurs following allogeneic
hematopoietic stem cell transplantation, which is a potential curative therapy used in a …

Ocular surface system alterations in ocular graft-versus-host disease: all the pieces of the complex puzzle

G Giannaccare, M Pellegrini, F Bernabei… - Graefe's Archive for …, 2019 - Springer
Purpose Graft-versus-host disease (GVHD) is a major complication of allogeneic
hematopoietic stem cells transplantation, occurring in about half of transplanted patients …

Ocular graft-versus-host disease after allogeneic stem cell transplantation

AC Westeneng, Y Hettinga, H Lokhorst, L Verdonck… - Cornea, 2010 - journals.lww.com
Purpose: To determine the prevalence and manifestations of ocular graft-versus-host
disease (GvHD) after allogeneic stem cell transplantation (allo-SCT). Methods: Prospective …